multi-color graphical image of the human genome
Media Coverage

Real-Time Hope for Rare Diseases


Advances in sequencing technology combined with AI tools that make it possible to analyze huge volumes of data very quickly, mean determining a patient's genetic disease can now be done within days or weeks, compared with months and years, and at a much lower cost than just a few years ago.

"The incredible investments in full genome sequencing and interpretation have allowed patients or their caregivers to quickly realize whether they are suffering from a monogenetic disorder," says David Fischer, Ph.D., executive director discovery sciences of Scientific Advisory Services at Charles River.

Read the full story